Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 150 (2), 413-419
- https://doi.org/10.1016/s0021-9150(99)00406-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitorBiochemical Journal, 1999
- The antiatherogenic role of high-density lipoprotein cholesterolThe American Journal of Cardiology, 1998
- Novel Function of Lecithin-Cholesterol AcyltransferaseJournal of Biological Chemistry, 1997
- Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteinsCurrent Opinion in Lipidology, 1996
- The role of oxidized lipoproteins in atherogenesisFree Radical Biology & Medicine, 1996
- Anti-inflammatory properties of a platelet-activating factor acetylhydrolaseNature, 1995
- Distribution of PAF-acetylhydrolase activity in human plasma low-density lipoprotein subfractionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarctionCoronary Artery Disease, 1993
- Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience)The American Journal of Cardiology, 1992
- Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke.Stroke, 1992